![]() |
|
|
Vol. 303, Issue 2, 534-539, November 2002
Department of Pharmacology and Toxicology, Kyorin
University School of Medicine, Tokyo, Japan (S.K., M.T., R.N., S.N.,
A.E., N.A., H.E.); and Department of Physiology, Faculty of Science,
Mahidol University, Bangkok, Thailand (S.K., P.P.)
The purpose of this study was to elucidate the interactions of human
organic anion transporters (hOATs) and human organic cation
transporters (hOCTs) with nonsteroidal anti-inflammatory drugs (NSAIDs)
using cells stably expressing hOATs and hOCTs. NSAIDs tested were
acetaminophen, acetylsalicylate, salicylate, diclofenac, ibuprofen,
indomethacin, ketoprofen, mefenamic acid, naproxen, piroxicam,
phenacetin, and sulindac. These NSAIDs inhibited organic anion uptake
mediated by hOAT1, hOAT2, hOAT3, and hOAT4. By comparing the
IC50 values of NSAIDs for hOATs, it was found that hOAT1
and hOAT3 exhibited higher affinity interactions with NSAIDs than did
hOAT2 and hOAT4. HOAT1, hOAT2, hOAT3, and hOAT4 mediated the uptake of
either ibuprofen, indomethacin, ketoprofen, or salicylate, but not
acetylsalicylate. Although organic cation uptake mediated by hOCT1 and
hOCT2 was also inhibited by some NSAIDs, hOCT1 and hOCT2 did not
mediate the uptake of NSAIDs. In conclusion, hOATs and hOCTs interacted
with various NSAIDs, whereas hOATs but not hOCTs mediated the transport
of some of these NSAIDs. Considering the localization of hOATs, it was
suggested that the interactions of hOATs with NSAIDs are associated
with the pharmacokinetics and the induction of adverse reactions of NSAIDs.
This article has been cited by other articles:
![]() |
E. Kumpulainen, H. Kokki, M. Laisalmi, M. Heikkinen, J. Savolainen, J. Rautio, and M. Lehtonen How Readily Does Ketorolac Penetrate Cerebrospinal Fluid in Children? J. Clin. Pharmacol., April 1, 2008; 48(4): 495 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kokki, E. Kumpulainen, M. Lehtonen, M. Laisalmi, M. Heikkinen, J. Savolainen, and J. Rautio Cerebrospinal Fluid Distribution of Ibuprofen After Intravenous Administration in Children Pediatrics, October 1, 2007; 120(4): e1002 - e1008. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mizuno, T. Takahashi, Y. Iwase, H. Kusuhara, T. Niwa, and Y. Sugiyama Human Organic Anion Transporters 1 (hOAT1/SLC22A6) and 3 (hOAT3/SLC22A8) Transport Edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one) and Its Sulfate Conjugate Drug Metab. Dispos., August 1, 2007; 35(8): 1429 - 1434. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nakai, K. Inoue, N. Abe, M. Hatakeyama, K.-y. Ohta, M. Otagiri, Y. Hayashi, and H. Yuasa Functional Characterization of Human Proton-Coupled Folate Transporter/Heme Carrier Protein 1 Heterologously Expressed in Mammalian Cells as a Folate Transporter J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 469 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mannila, E. Kumpulainen, M. Lehtonen, M. Heikkinen, M. Laisalmi, T. Salo, J. Rautio, J. Savolainen, and H. Kokki Plasma and Cerebrospinal Fluid Concentrations of Indomethacin in Children After Intravenous Administration J. Clin. Pharmacol., January 1, 2007; 47(1): 94 - 100. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bakhiya, M. Stephani, A. Bahn, B. Ugele, A. Seidel, G. Burckhardt, and H. Glatt Uptake of Chemically Reactive, DNA-Damaging Sulfuric Acid Esters into Renal Cells by Human Organic Anion Transporters J. Am. Soc. Nephrol., May 1, 2006; 17(5): 1414 - 1421. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Dai, Y. Chen, and W. F. Elmquist Distribution of the Novel Antifolate Pemetrexed to the Brain J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 222 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C Whitley, D. H. Sweet, and T. Walle THE DIETARY POLYPHENOL ELLAGIC ACID IS A POTENT INHIBITOR OF hOAT1 Drug Metab. Dispos., August 1, 2005; 33(8): 1097 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Morita, H. Kusuhara, Y. Nozaki, H. Endou, and Y. Sugiyama FUNCTIONAL INVOLVEMENT OF RAT ORGANIC ANION TRANSPORTER 2 (SLC22A7) IN THE HEPATIC UPTAKE OF THE NONSTEROIDAL ANTI-INFLAMMATORY DRUG KETOPROFEN Drug Metab. Dispos., August 1, 2005; 33(8): 1151 - 1157. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Srimaroeng, V. Chatsudthipong, A. G. Aslamkhan, and J. B. Pritchard Transport of the Natural Sweetener Stevioside and Its Aglycone Steviol by Human Organic Anion Transporter (hOAT1; SLC22A6) and hOAT3 (SLC22A8) J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 621 - 628. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Wright and W. H. Dantzler Molecular and Cellular Physiology of Renal Organic Cation and Anion Transport Physiol Rev, July 1, 2004; 84(3): 987 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zhou, K. Tanaka, Z. Pan, J. Ma, and G. You The Role of Glycine Residues in the Function of Human Organic Anion Transporter 4 Mol. Pharmacol., May 1, 2004; 65(5): 1141 - 1147. [Abstract] [Full Text] |
||||
![]() |
H. Hasannejad, M. Takeda, K. Taki, H. J. Shin, E. Babu, P. Jutabha, S. Khamdang, M. Aleboyeh, M. L. Onozato, A. Tojo, et al. Interactions of Human Organic Anion Transporters with Diuretics J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 1021 - 1029. [Abstract] [Full Text] [PDF] |
||||